Literature DB >> 22157635

Lack of association between the regulator of G-protein signaling 4 (RGS4) rs951436 polymorphism and schizophrenia.

Erik G Jönsson, Peter Saetre, Helena Nyholm, Srdjan Djurovic, Ingrid Melle, Ole A Andreassen, Celina Skjødt, Johan H Thygesen, Thomas Werge, Håkan Hall, Ingrid Agartz, Lars Terenius.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22157635     DOI： 10.1097/YPG.0b013e32834f3558

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN： 0955-8829            Impact factor:   2.458


× No keyword cloud information.
  5 in total

1.  Perinatal Treatments with the Dopamine D₂-Receptor Agonist Quinpirole Produces Permanent D₂-Receptor Supersensitization: a Model of Schizophrenia.

Authors:  Richard M Kostrzewa; Przemysław Nowak; Ryszard Brus; Russell W Brown
Journal:  Neurochem Res       Date:  2015-11-07       Impact factor: 3.996

2.  Large Scale Gene Expression Meta-Analysis Reveals Tissue-Specific, Sex-Biased Gene Expression in Humans.

Authors:  Benjamin T Mayne; Tina Bianco-Miotto; Sam Buckberry; James Breen; Vicki Clifton; Cheryl Shoubridge; Claire T Roberts
Journal:  Front Genet       Date:  2016-10-13       Impact factor: 4.599

3.  Association Analysis Between SNPs in the Promoter Region of RGS4 and Schizophrenia in the Northern Chinese Han Population.

Authors:  Feng-Ling Xu; Jun Yao; Xue Wu; Xi Xia; Jia-Xin Xing; Jin-Feng Xuan; Yong-Ping Liu; Bao-Jie Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-04-16       Impact factor: 2.570

4.  Expression of the Longest RGS4 Splice Variant in the Prefrontal Cortex Is Associated with Single Nucleotide Polymorphisms in Schizophrenia Patients.

Authors:  Lan Ding; Miroslav Styblo; Zuzana Drobná; Ashok N Hegde
Journal:  Front Psychiatry       Date:  2016-02-29       Impact factor: 4.157

5.  Association between RGS4 gene polymorphisms and schizophrenia: A protocol for systematic review and meta-analysis.

Authors:  Feng-Ling Xu; Jun Yao; Bao-Jie Wang
Journal:  Medicine (Baltimore)       Date:  2021-11-05       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.